Skip to main content

Day: February 18, 2022

Invitation to an Investor Call on SSH Communications Security Corporation’s Interim Report, October 1 – December 31, 2021

INVITATION TO AN INVESTOR CALL ON SSH COMMUNICATIONS SECURITY CORPORATION’S INTERIM REPORT, OCTOBER 1 – DECEMBER 31, 2021 Helsinki, Finland SSH Communications Security’s Interim Report October 1 – December 31, 2021, will be published on Thursday, February 24, 2022, at approximately 09.00 EET. A conference call for media, investors, and analysts will be held at 10.00 EET on the same day. The financial statement release will be presented by SSH CEO Dr. Teemu Tunkelo and CFO Niklas Nordström. The presentation materials (in English) will be available on the SSH Communications Security’s website (www.ssh.com) after the conference call. Time: February 24, 2022, at 10.00–11.00 EET Place: Video call To join the meeting, please register no later than Tuesday, February 22 at 16.00 EET by sending an email to kristian.nieminen@ssh.com. Conference...

Continue reading

AirSculpt Technologies Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., Feb. 18, 2022 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) today announced that the company will release its fourth quarter and full year results before market open on Friday, March 11, 2022, to be followed by a conference call on the same day at 8:30 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-9716 or for international callers, 1-201-493-6779. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13726492. The replay will be available until March 18, 2022. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor...

Continue reading

Chinook Therapeutics Announces Upcoming Encore Presentations at ISN World Congress of Nephrology 2022

SEATTLE, Feb. 18, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming presentations at the ISN World Congress of Nephrology 2022 from February 24 – 27, 2022. The following abstracts will be presented as poster presentations at the ISN World Congress of Nephrology 2022:Atrasentan      Abstract WCN22-0484     A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)Author:     Hiddo J. L. Heerspink, PhD, PharmD, University Medical Center Groningen, Groningen, Netherlands       Abstract WCN22-0480     Atrasentan in Patients with Proteinuric Glomerular Diseases (The AFFINITY Study)Author:     Anjay...

Continue reading

Verisk Announces Leadership Succession

Scott G. Stephenson Headshot Scott G. Stephenson HeadshotLee M. Shavel Headshot Lee M. Shavel HeadshotMark V. Anquillare Headshot Mark V. Anquillare HeadshotScott G. Stephenson to retire from Verisk following 2022 Annual Meeting Lee M. Shavel named CEO, effective upon Stephenson’s retirement Mark V. Anquillare to become president Roles of Chairman and CEO to be separated upon Stephenson’s retirement JERSEY CITY, N.J., Feb. 18, 2022 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics provider, today announced that Scott G. Stephenson, Chairman, President and CEO of Verisk, will be retiring from the company following Verisk’s 2022 Annual Shareholder Meeting. The Verisk Board of Directors has named Lee M. Shavel, currently CFO of Verisk and group president, to become CEO upon Stephenson’s retirement....

Continue reading

Osisko Development Intersects 26.5 g/t Au Over 1.5 Meters and 0.92 g/t Au Over 37.5 Meters at California Target – San Antonio Project

Figure 1: San Antonio Mineral Zones overview map Figure 1: San Antonio Mineral Zones overview mapFigure 2: California Plan Map Figure 2: California Plan MapFigure 3: California Section select drilling highlights Figure 3: California Section select drilling highlightsMONTREAL, Feb. 18, 2022 (GLOBE NEWSWIRE) — Osisko Development Corp. (“Osisko Development” or the “Company”) (TSX.V-ODV) is pleased to announce drilling results from the 2021 exploration and category conversion drill program campaign at its San Antonio Project in Sonora State, Mexico. SummaryA total of 177 holes and 27,900 meters were drilled in 2021. The objective of the drill program was to conduct exploration and resource drilling at a spacing of 25 meters and historic drilling validation for the three main target areas (Figure 1). This news releases encompasses...

Continue reading

Arbor Realty Trust Reports Fourth Quarter and Full Year 2021 Results and Increases Dividend for Seventh Consecutive Quarter to $0.37 per Share

Fourth Quarter Highlights:Diversified, annuity-based operating platform with a multifamily focus that generates strong distributable earnings and dividends in all cyclesGAAP net income of $0.71 and distributable earnings of $0.57 per diluted common share1 Raised cash dividend on common stock to $0.37 per share, our seventh consecutive quarterly increase Successfully raised $533 million of accretive capital to fund the significant growth of our structured portfolioStructured Business:Record loan originations of $4.32 billion, a 75% increase over last quarter and our third consecutive quarter of record originations Structured loan portfolio of over $12 billion on substantial growth of 33% Closed a $2.10 billion collateralized securitization vehicle, our largest to dateAgency Business:Loan originations of $1.89 billion and a...

Continue reading

Aterian Announces Upcoming Investor Conference Schedule

Management Will Present At Two Conferences In March 2022 NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or “The Company”) today announced its upcoming investor conference schedule. The Company will participate in two conferences during the month of March 2022. DA Davidson 5th Annual Consumer Growth ConferenceThe Company will be participating in one on one meetings with investors on Thursday, March 10, 2022 at the DA Davidson 5th Annual Consumer Growth Conference. 34th Annual Roth ConferenceThe Company will be participating in one on one meetings with investors on Monday, March 14th and Tuesday, March 15th, 2022 at the 34th Annual Roth Conference in Dana Point, California. About Aterian, Inc.Aterian, Inc. (Nasdaq: ATER), is a leading technology-enabled consumer products platform that builds, acquires,...

Continue reading

Acerus Announces Amendment to Loan Facilities

Pays off SWK Facility; Reduces Interest Going Forward TORONTO, Feb. 18, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with First Generation Capital Inc. (“First Generation”), a company affiliated with the Chairman of the Board of Directors of Acerus1, to increase its secured loan facility (the “Loan Facility”) from US$25 million to US$30.845 million. This increase was made available to the Company by way of a single advance under a secured grid promissory note with First Generation. The proceeds from the Loan Facility increase were used on February 17, 2022 to settle all obligations under the former senior loan facility with SWK Funding LLC (“SWK”). “The Company and Board wish to once again thank First...

Continue reading

Eve & Co Announces Closing of Shares for Debt Transaction

STRATHROY, Ontario, Feb. 18, 2022 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has closed its previously announced shares for debt transaction (the “Transaction”) whereby it settled $657,000 in payables (the “Payables”) owed to certain directors, officers, employees, and debentureholders related to expenses, loans, and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,607 common shares in the capital of the Company (the “Settlement Shares”). The Company issued the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes. Pursuant to the Transaction, the Company has issued an aggregate of 908,677 Settlement Shares at a deemed issuance price of $0.12 per Settlement...

Continue reading

Shawcor Receives Contract for Application of Unique LotusFlo® Scale, Asphaltene and Wax Reduction Technology

TORONTO, Feb. 18, 2022 (GLOBE NEWSWIRE) — Shawcor Ltd. (“Shawcor” or the “Company”) (TSX: SCL) today announced that its pipe coating division has been awarded a three year contract with Vallourec S.A. to apply the unique LotusFlo® technology to offshore downhole production tubulars designed for the Buzios oilfields. The Buzios oilfields are located off the coast of Brazil and operated by Petróleo Brasileiro S.A. (“Petrobras”). With this award, Shawcor will increase its total current orders for this technology, including additional orders in the Gulf of Mexico market, to a range of C$18M-C$25M. The work will be executed out of Shawcor’s Channelview facility and is expected to commence in the fourth quarter of 2022, continuing over a multi-year period on an as-needed basis. LotusFlo is an innovative diamond-like carbon coating technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.